AVOBENZONE,HOMOSALATE,OCTOCRYLENE,OCTISALATE

AVOBENZONE,HOMOSALATE,OCTOCRYLENE,OCTISALATE was reported 149 times

AVOBENZONE,HOMOSALATE,OCTOCRYLENE,OCTISALATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL MELANOSIS 1 0.0182
1 PINGUECULA 1 0.0094
2 EXPOSURE TO MOULD 1 0.0079
3 APPLICATION SITE NODULE 1 0.0073
4 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
5 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
6 XEROSIS 5 0.0040
7 LENTIGO 2 0.0040
8 SOLAR DERMATITIS 1 0.0037
9 CHEMICAL BURNS OF EYE 1 0.0036
10 PYOGENIC GRANULOMA 1 0.0021
11 HYPEREOSINOPHILIC SYNDROME 1 0.0018
12 APPLICATION SITE DISCHARGE 2 0.0017
13 FUNGAL OESOPHAGITIS 1 0.0014
14 SEBORRHOEIC KERATOSIS 2 0.0014
15 GUTTATE PSORIASIS 1 0.0012
16 SUNBURN 9 0.0012
17 MILIARIA 2 0.0012
18 INJECTION SITE DRYNESS 1 0.0011
19 C-REACTIVE PROTEIN 1 0.0011
20 FACIAL ASYMMETRY 1 0.0010
21 IMMUNE-MEDIATED HEPATITIS 2 0.0010
22 CHEMICAL BURN 1 0.0009
23 MALIGNANT MELANOMA IN SITU 1 0.0008
24 JOINT WARMTH 1 0.0008
25 SKIN DEPIGMENTATION 1 0.0007
26 MENINGITIS VIRAL 1 0.0007
27 VASCULAR INJURY 1 0.0007
28 CONJUNCTIVITIS ALLERGIC 1 0.0007
29 ACNE CYSTIC 2 0.0007
30 PIGMENTATION DISORDER 4 0.0006
31 SEBORRHOEIC DERMATITIS 1 0.0006
32 ARTHROPOD STING 1 0.0006
33 MALIGNANT MELANOMA 8 0.0006
34 SKIN HYPOPIGMENTATION 1 0.0006
35 CHEILITIS 3 0.0006
36 NASAL OEDEMA 1 0.0006
37 APPLICATION SITE DISCOLOURATION 2 0.0005
38 DERMATITIS PSORIASIFORM 1 0.0005
39 APPLICATION SITE EXFOLIATION 2 0.0005
40 WALKING DISABILITY 1 0.0005
41 APPLICATION SITE SCAB 1 0.0005
42 MELANOCYTIC NAEVUS 2 0.0005
43 METASTATIC MALIGNANT MELANOMA 1 0.0004
44 HAEMANGIOMA 1 0.0004
45 VITILIGO 1 0.0004
46 EYE OEDEMA 1 0.0004
47 SENSITIVE SKIN 3 0.0004
48 ACTINIC KERATOSIS 1 0.0004
49 SKIN DISCOMFORT 1 0.0004
50 APPLICATION SITE HAEMORRHAGE 1 0.0004
51 PHOTOSENSITIVITY REACTION 6 0.0004
52 RED BLOOD CELL COUNT INCREASED 1 0.0004
53 VITREOUS HAEMORRHAGE 1 0.0004
54 CHOLECYSTITIS ACUTE 2 0.0004
55 SKIN HYPERPIGMENTATION 3 0.0003
56 SKIN WARM 2 0.0003
57 TONGUE ULCERATION 1 0.0003
58 ABNORMAL LOSS OF WEIGHT 2 0.0003
59 DERMATITIS 6 0.0003
60 SCLERODERMA 1 0.0003
61 INTENTIONAL UNDERDOSE 2 0.0003
62 OESOPHAGEAL ULCER 1 0.0003
63 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
64 BASAL CELL CARCINOMA 4 0.0003
65 MIOSIS 2 0.0002
66 TRIGGER FINGER 1 0.0002
67 SELF-INJURIOUS IDEATION 1 0.0002
68 OCULAR ICTERUS 1 0.0002
69 APPLICATION SITE ERYTHEMA 6 0.0002
70 SKIN TIGHTNESS 1 0.0002
71 SQUAMOUS CELL CARCINOMA 2 0.0002
72 ENDOMETRIOSIS 1 0.0002
73 INCORRECT DOSAGE ADMINISTERED 1 0.0002
74 ORGANISING PNEUMONIA 1 0.0002
75 APPLICATION SITE SWELLING 1 0.0002
76 AMMONIA INCREASED 1 0.0002
77 ANAL FISTULA 1 0.0002
78 APPLICATION SITE PAIN 4 0.0002
79 HYPERKERATOSIS 1 0.0002
80 ANGIOPATHY 1 0.0002
81 ACUTE PULMONARY OEDEMA 1 0.0002
82 SKIN ATROPHY 1 0.0002
83 RALES 1 0.0002
84 HYPERTRIGLYCERIDAEMIA 1 0.0002
85 CATARACT OPERATION 1 0.0002
86 PRE-EXISTING CONDITION IMPROVED 1 0.0002
87 APPLICATION SITE VESICLES 1 0.0002
88 IMMUNE SYSTEM DISORDER 2 0.0002
89 SKIN MASS 1 0.0001
90 PAIN OF SKIN 4 0.0001
91 DROOLING 1 0.0001
92 ENCEPHALITIS 1 0.0001
93 RETINAL HAEMORRHAGE 1 0.0001
94 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
95 SKIN HAEMORRHAGE 2 0.0001
96 ACNE 10 0.0001
97 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
98 PULMONARY HAEMORRHAGE 1 0.0001
99 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
100 MUSCLE DISORDER 1 0.0001
101 HYPERAESTHESIA 1 0.0001
102 SKIN PLAQUE 1 0.0001
103 CARDIAC MURMUR 1 0.0001
104 NAIL DISORDER 1 0.0001
105 BLOOD CALCIUM INCREASED 1 0.0001
106 IMMUNOSUPPRESSION 1 0.0001
107 LIP DRY 1 0.0001
108 MOOD ALTERED 3 0.0001
109 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
110 SPINAL DISORDER 1 0.0001
111 CHOLESTASIS 2 0.0001
112 PETECHIAE 1 0.0001
113 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
114 SCRATCH 1 0.0001
115 SWELLING FACE 6 0.0001
116 ASPIRATION 1 0.0001
117 NERVE INJURY 1 0.0001
118 RASH PAPULAR 2 0.0001
119 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
120 BLISTER 5 0.0001
121 DERMATITIS CONTACT 1 0.0001
122 SCAB 1 0.0001
123 VASCULITIS 1 0.0001
124 CARDIOMEGALY 1 0.0001
125 APPLICATION SITE IRRITATION 1 0.0001
126 HAIR COLOUR CHANGES 1 0.0001
127 DRY EYE 4 0.0001
128 NODULE 1 0.0001
129 ECZEMA 4 0.0001
130 INCORRECT PRODUCT STORAGE 1 0.0001
131 TACHYPNOEA 1 0.0001
132 SKIN LESION 2 0.0001
133 APPLICATION SITE RASH 1 0.0001
134 SKIN EXFOLIATION 6 0.0001
135 SKIN REACTION 1 0.0001
136 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
137 BRONCHOSPASM 1 0.0001
138 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
139 DRY SKIN 9 0.0001
140 SKIN IRRITATION 3 0.0001
141 SKIN DISCOLOURATION 3 0.0001
142 RASH ERYTHEMATOUS 3 0.0001
143 BACK DISORDER 1 0.0001
144 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
145 SCAR 1 0.0001
146 MUSCULOSKELETAL DISCOMFORT 1 0.0001
147 RASH MACULAR 2 0.0001
148 THIRST 1 0.0001
149 SKIN BURNING SENSATION 4 0.0001
150 GASTROENTERITIS VIRAL 1 0.0001
151 OSTEOMYELITIS 1 0.0001
152 BACTERIAL INFECTION 1 0.0001
153 GASTRIC ULCER 1 0.0001
154 DISABILITY 1 0.0001
155 PSORIATIC ARTHROPATHY 2 0.0000
156 INJURY ASSOCIATED WITH DEVICE 1 0.0000
157 LUNG NEOPLASM MALIGNANT 2 0.0000
158 ERYTHEMA 10 0.0000
159 MOUTH ULCERATION 1 0.0000
160 LIVER FUNCTION TEST INCREASED 1 0.0000
161 SKIN CANCER 1 0.0000
162 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
163 RASH MACULO-PAPULAR 1 0.0000
164 GLOSSODYNIA 1 0.0000
165 APPLICATION SITE PRURITUS 1 0.0000
166 BURNING SENSATION 3 0.0000
167 UNDERDOSE 3 0.0000
168 HYPOPHAGIA 1 0.0000
169 HEPATITIS 1 0.0000
170 INFLAMMATION 2 0.0000
171 PSORIASIS 5 0.0000
172 JAUNDICE 1 0.0000
173 FREQUENT BOWEL MOVEMENTS 1 0.0000
174 WOUND 1 0.0000
175 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
176 EYE PAIN 2 0.0000
177 INTENTIONAL DOSE OMISSION 1 0.0000
178 HYPERSOMNIA 1 0.0000
179 EYE IRRITATION 2 0.0000
180 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
181 INTENTIONAL PRODUCT MISUSE 3 0.0000
182 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
183 ASCITES 1 0.0000
184 PSYCHOTIC DISORDER 1 0.0000
185 URINARY INCONTINENCE 1 0.0000
186 RESPIRATORY DISORDER 1 0.0000
187 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
188 RASH 14 0.0000
189 HEART RATE INCREASED 3 0.0000
190 EXPIRED PRODUCT ADMINISTERED 1 0.0000
191 SKIN DISORDER 1 0.0000
192 URINARY RETENTION 1 0.0000
193 TYPE 2 DIABETES MELLITUS 1 0.0000
194 HAEMATURIA 1 0.0000
195 ILLNESS 3 0.0000
196 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
197 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
198 MYELOSUPPRESSION 1 0.0000
199 DRUG EFFECT INCOMPLETE 1 0.0000
200 HYPERGLYCAEMIA 1 0.0000
201 INJECTION SITE MASS 1 0.0000
202 PRODUCT USE ISSUE 5 0.0000
203 DYSPNOEA EXERTIONAL 1 0.0000
204 PLASMA CELL MYELOMA 1 0.0000
205 DRY MOUTH 2 0.0000
206 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
207 RECTAL HAEMORRHAGE 1 0.0000
208 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
209 TACHYCARDIA 2 0.0000
210 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
211 DEPRESSION 5 0.0000
212 NEPHROLITHIASIS 1 0.0000
213 ADVERSE EVENT 2 0.0000
214 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
215 HYPERSENSITIVITY 4 0.0000
216 BLOOD CHOLESTEROL INCREASED 1 0.0000
217 SWELLING 2 0.0000
218 OCULAR HYPERAEMIA 1 0.0000
219 DYSPHAGIA 2 0.0000
220 DISEASE RECURRENCE 1 0.0000
221 PRODUCTIVE COUGH 1 0.0000
222 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
223 CONTUSION 2 0.0000
224 DRUG INTOLERANCE 2 0.0000
225 SOMNOLENCE 4 0.0000
226 HOSPITALISATION 3 0.0000
227 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
228 RASH PRURITIC 1 0.0000
229 OEDEMA 1 0.0000
230 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
231 URTICARIA 3 0.0000
232 OXYGEN SATURATION DECREASED 1 0.0000
233 FLATULENCE 1 0.0000
234 CONVULSION 1 0.0000
235 SEIZURE 2 0.0000
236 NASAL CONGESTION 1 0.0000
237 JOINT SWELLING 2 0.0000
238 STOMATITIS 1 0.0000
239 CONDITION AGGRAVATED 5 0.0000
240 DISCOMFORT 1 0.0000
241 FEELING HOT 1 0.0000
242 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
243 HYPERHIDROSIS 2 0.0000
244 PRODUCT DOSE OMISSION 1 0.0000
245 BLOOD PRESSURE DECREASED 1 0.0000
246 INJECTION SITE PRURITUS 1 0.0000
247 PRODUCT QUALITY ISSUE 2 0.0000
248 INJECTION SITE REACTION 1 0.0000
249 SLEEP DISORDER 1 0.0000
250 MOBILITY DECREASED 1 0.0000
251 INFECTION 2 0.0000
252 RESPIRATORY FAILURE 1 0.0000
253 EPISTAXIS 1 0.0000
254 HOT FLUSH 1 0.0000
255 DIABETES MELLITUS 1 0.0000
256 INJECTION SITE SWELLING 1 0.0000
257 PRURITUS 5 0.0000
258 PERIPHERAL SWELLING 2 0.0000
259 INJECTION SITE HAEMORRHAGE 1 0.0000
260 INFLUENZA LIKE ILLNESS 1 0.0000
261 ARTHRALGIA 5 0.0000
262 ABDOMINAL DISCOMFORT 2 0.0000
263 MYALGIA 2 0.0000
264 BALANCE DISORDER 1 0.0000
265 PRODUCT STORAGE ERROR 1 0.0000
266 MUSCULOSKELETAL STIFFNESS 1 0.0000
267 HEADACHE 7 0.0000
268 GASTROINTESTINAL DISORDER 1 0.0000
269 SUICIDAL IDEATION 1 0.0000
270 MUSCLE SPASMS 2 0.0000
271 WEIGHT DECREASED 3 0.0000
272 COUGH 3 0.0000
273 ANXIETY 3 0.0000
274 PULMONARY EMBOLISM 1 0.0000
275 MIGRAINE 1 0.0000
276 ATRIAL FIBRILLATION 1 0.0000
277 DYSPEPSIA 1 0.0000
278 FLUSHING 1 0.0000
279 PAIN 6 0.0000
280 ABDOMINAL PAIN UPPER 2 0.0000
281 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
282 ABDOMINAL DISTENSION 1 0.0000
283 HAEMORRHAGE 1 0.0000
284 OVERDOSE 2 0.0000
285 OFF LABEL USE 8 0.0000
286 MALAISE 4 0.0000
287 SEPSIS 1 0.0000
288 ASTHMA 1 0.0000
289 MUSCULAR WEAKNESS 1 0.0000
290 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
291 DECREASED APPETITE 2 0.0000
292 BACK PAIN 2 0.0000
293 PALPITATIONS 1 0.0000
294 DISEASE PROGRESSION 1 0.0000
295 ASTHENIA 3 0.0000
296 DIARRHOEA 5 0.0000
297 DEHYDRATION 1 0.0000
298 NEUTROPENIA 1 0.0000
299 VISION BLURRED 1 0.0000
300 PRODUCT DOSE OMISSION ISSUE 2 0.0000
301 PAIN IN EXTREMITY 2 0.0000
302 BLOOD PRESSURE INCREASED 1 0.0000
303 ACUTE KIDNEY INJURY 1 0.0000
304 FATIGUE 5 0.0000
305 CONFUSIONAL STATE 1 0.0000
306 PNEUMONIA 2 0.0000
307 FALL 2 0.0000
308 CEREBROVASCULAR ACCIDENT 1 0.0000
309 PYREXIA 2 0.0000
310 COVID-19 1 0.0000
311 NASOPHARYNGITIS 1 0.0000
312 CHEST PAIN 1 0.0000
313 BLOOD GLUCOSE INCREASED 1 0.0000
314 ANAEMIA 1 0.0000
315 GAIT DISTURBANCE 1 0.0000
316 ALOPECIA 1 0.0000
317 HYPOTENSION 1 0.0000
318 HYPERTENSION 1 0.0000
319 CONSTIPATION 1 0.0000
320 DRUG INEFFECTIVE 6 0.0000
321 WEIGHT INCREASED 1 0.0000
322 ABDOMINAL PAIN 1 0.0000
323 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
324 NAUSEA 3 0.0000
325 INSOMNIA 1 0.0000
326 DYSPNOEA 2 0.0000
327 INJECTION SITE PAIN 1 0.0000
328 DEATH 2 0.0000
329 VOMITING 1 0.0000